TP-0184 inhibits FLT3/ACVR1 to overcome FLT3 inhibitor resistance and hinder AML growth synergistically with venetoclax

Leukemia, Published online: 25 November 2023; doi:10.1038/s41375-023-02086-6TP-0184 inhibits FLT3/ACVR1 to overcome FLT3 inhibitor resistance and hinder AML growth synergistically with venetoclax

Source: Leukemia - November 25, 2023 Category: Hematology Authors: Anudishi Tyagi Appalaraju Jaggupilli Stanley Ly Bin Yuan Fouad El-Dana Venkatesh L. Hegde Vivek Anand Bijender Kumar Mamta Puppala Zheng Yin Stephen T. C. Wong Alexis Mollard Hariprasad Vankayalapati Jason M. Foulks Steven L. Warner Naval Daver Gautam Bor Source Type: research